Ignite Creation Date:
2025-12-24 @ 10:16 PM
Ignite Modification Date:
2026-02-27 @ 10:34 AM
Study NCT ID:
NCT06767735
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-28
First Post:
2025-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
Sponsor:
Gan & Lee Pharmaceuticals.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-17
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-05
First Submit QC Date:
None
Study First Post Date:
2025-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-23
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED